- Home
- WSR vs PCRX Comparison
WSR vs PCRX Comparison
Compare WSR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSR
- PCRX
- Stock Information
- Founded
- WSR 1998
- PCRX 2006
- Country
- WSR United States
- PCRX United States
- Employees
- WSR N/A
- PCRX N/A
- Industry
- WSR Real Estate Investment Trusts
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- WSR Real Estate
- PCRX Health Care
- Exchange
- WSR Nasdaq
- PCRX Nasdaq
- Market Cap
- WSR 739.7M
- PCRX 604.7M
- IPO Year
- WSR 2010
- PCRX 2011
- Fundamental
- Price
- WSR $14.33
- PCRX $16.52
- Analyst Decision
- WSR Strong Buy
- PCRX Buy
- Analyst Count
- WSR 3
- PCRX 10
- Target Price
- WSR $15.00
- PCRX $26.60
- AVG Volume (30 Days)
- WSR 245.9K
- PCRX 545.3K
- Earning Date
- WSR 10-30-2024
- PCRX 11-06-2024
- Dividend Yield
- WSR 3.45%
- PCRX N/A
- EPS Growth
- WSR N/A
- PCRX N/A
- EPS
- WSR 0.41
- PCRX N/A
- Revenue
- WSR $149,446,000.00
- PCRX $694,957,000.00
- Revenue This Year
- WSR N/A
- PCRX $4.59
- Revenue Next Year
- WSR $4.35
- PCRX N/A
- P/E Ratio
- WSR $34.91
- PCRX N/A
- Revenue Growth
- WSR 4.67
- PCRX 4.40
- 52 Week Low
- WSR $10.77
- PCRX $11.16
- 52 Week High
- WSR $14.80
- PCRX $35.95
- Technical
- Relative Strength Index (RSI)
- WSR 54.38
- PCRX 44.28
- Support Level
- WSR $13.55
- PCRX $16.11
- Resistance Level
- WSR $14.80
- PCRX $18.34
- Average True Range (ATR)
- WSR 0.31
- PCRX 0.83
- MACD
- WSR -0.00
- PCRX -0.17
- Stochastic Oscillator
- WSR 62.00
- PCRX 5.33
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. Its property portfolio includes retail and office/flex properties. The company's properties are located in business-friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The organization derives revenue in the form of rental revenues.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.